Skip to main content

Anticoagulant Citrate Dextrose A

Generic: Anhydrous Citric Acid, Dextrose Monohydrate, and Trisodium Citrate Dihydrate

Verified·Apr 23, 2026
Manufacturer
Baxter Healthcare Corporation
NDC
23731-6051
Route
EXTRACORPOREAL
ICD-10 indication
M77.9

Affordability Check

How much will you actually pay for Anticoagulant Citrate Dextrose A?

In 30 seconds, see every legitimate way to afford Anticoagulant Citrate Dextrose A — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Anticoagulant Citrate Dextrose A

What is this medication? Anticoagulant Citrate Dextrose A, commonly referred to as ACD-A, is a sterile solution used primarily as an anticoagulant to prevent blood from clotting during medical procedures that take place outside the body. It consists of a combination of citric acid, sodium citrate, and dextrose. When added to whole blood, the citrate ions work by binding with calcium ions, which are essential for the blood to form clots. By effectively removing available calcium from the blood stream, the solution ensures that blood remains in a liquid state for processing or storage. This medication is most frequently utilized during automated blood collection processes such as apheresis, where specific components like plasma or platelets are separated from the blood and the remaining portions are returned to the donor. It is also used in the preparation of various blood products and in certain types of renal replacement therapy. The inclusion of dextrose in the formula provides a necessary energy source for the red blood cells, helping to maintain their health while they are being handled. Because it acts specifically on the blood being processed, it is a critical tool for ensuring safe and efficient extracorporeal treatments.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Anticoagulant Citrate Dextrose A. Official source: DailyMed (NLM) · Label effective Feb 14, 2023

Indications and usage
Indications and Usage Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P. (ACD-A), is intended for use as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP). Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.
Dosage and administration
Dosage and Administration Refer to the manufacturer's Operator's Manual of the Autologous PRP System for the Directions for Use.
Contraindications
Contraindications NOT FOR DIRECT INTRAVENOUS INFUSION
Warnings
Warnings NOT FOR DIRECT INTRAVENOUS INFUSION
Adverse reactions
Adverse Reactions Not applicable. This product is used as an anticoagulant in the extracorporeal blood processing with Autologous PRP Systems in production of platelet rich plasma (PRP).
Use in pregnancy
Pregnancy Long-term studies in animals have not been performed to evaluate the effects of ACD- A on pregnant women.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.